St. Jude Children's Research Hospital Welcomes Carsten Bönnemann, MD, to Lead New Neuroscience Department Dr. Carsten Bönnemann has been appointed to head St. Jude's new Department of Genomic and Translational Neuroscience, focusing on pediatric neurological disorders.

St. Jude Children's Research Hospital Welcomes Carsten Bönnemann, MD, to Lead New Neuroscience Department #USA #Memphis #Neurological_Disorders #St._Jude #Carsten_Bönnemann

Valinor and Renew Forge Groundbreaking Partnership for Advancing Neurological Research with Multi-Omics Data Valinor and Renew Biotechnologies have partnered to create the largest clinical multi-omics dataset aimed at advancing neurological disease research and therapies.

Valinor and Renew Forge Groundbreaking Partnership for Advancing Neurological Research with Multi-Omics Data #USA #Salt_Lake_City #Neurological_Disorders #Renew_Biotechnologies #Valinor

Understanding Structural Determinants of Constitutive Activity in Histamine H3 Receptors: Implications for Neurological Disease Treatment This article explores the recent findings on the histamine H3 receptor, revealing how structural mutations enhance its activity, paving the way for new treatments in neurology.

Understanding Structural Determinants of Constitutive Activity in Histamine H3 Receptors: Implications for Neurological Disease Treatment #Japan #Tokyo #Neurological_Disorders #Histamine_H3_Receptor #G_Protein_Coupled_Receptor

Modulight Biotherapeutics Secures $12 Million to Advance Optogenetic Treatments for Neurological Diseases Modulight Biotherapeutics has concluded a successful $12.2 million Seed funding round, aimed at enhancing its cutting-edge optogenetic technology for treating neurological disorders.

Modulight Biotherapeutics Secures $12 Million to Advance Optogenetic Treatments for Neurological Diseases #United_States #Boston #Neurological_Disorders #Optogenetics #Modulight

Wearable EEG Devices Market Forecasted to Reach USD 695.51 Million by 2031 Amid Rising Neurological Disorders The wearable EEG devices market is projected to grow significantly, reaching USD 695.51 million by 2031, driven by an increase in neurological disorders and TBIs.

Wearable EEG Devices Market Forecasted to Reach USD 695.51 Million by 2031 Amid Rising Neurological Disorders #USA #New_York #Neurological_Disorders #Wearable_EEG #Brain_Monitoring

World Brain Day 2025: Promoting Lifelong Brain Health for Everyone Discover the themes and goals of World Brain Day 2025, emphasizing brain health across all life stages, from preconception to aging.

World Brain Day 2025: Promoting Lifelong Brain Health for Everyone #USA #London #Neurological_Disorders #Brain_Health #World_Federation_of_Neurology

Raising Awareness for GBS and CIDP: A Global Initiative in Healthcare The GBS | CIDP Foundation International launches the Awareness Month campaign to educate healthcare professionals on critical nerve disorders impacting many lives.

Raising Awareness for GBS and CIDP: A Global Initiative in Healthcare #United_States #Neurological_Disorders #Conshohocken #CIDP_Foundation #GBS_Awareness_Month

Using cutting-edge tools like #focused_ultrasound and advanced brain imaging, Dr Bojana Stefanovic & Dr Meaghan O’Reilly, researchers at @sunnybrookhsc.bsky.social & @uoft.bsky.social, are developing innovative, non-invasive treatments for #neurological_disorders.

futurumcareers.com/can-function...

Interventional Neuroradiology Market Set to Exceed $50 Billion by 2032, Driven by Rising Neurological Disorders DelveInsight's report predicts a significant growth in the interventional neuroradiology market, reaching over $50 billion by 2032 with North America leading.

Interventional Neuroradiology Market Set to Exceed $50 Billion by 2032, Driven by Rising Neurological Disorders #USA #Las_Vegas #Medical_Devices #Neurological_Disorders #Interventional_Neuroradiology

Cerebrospinal Fluid Management Market Set for Significant Growth, Expected to Reach $3.8 Billion by 2031 The CSF Management Market is poised for substantial expansion, projected to reach $3.8 billion by 2031, driven by rising neurological disorders and advanced medical device innovation.

Cerebrospinal Fluid Management Market Set for Significant Growth, Expected to Reach $3.8 Billion by 2031 #None #Medical_Devices #Neurological_Disorders #Cerebrospinal_Fluid

Exploring the Growth and Future of Divalproex Sodium API Market from 2024 to 2030 The Divalproex Sodium API market is set to grow at a CAGR of 6.2% from 2024 to 2030, driven by rising demands in neurological treatments and generic drug production.

Exploring the Growth and Future of Divalproex Sodium API Market from 2024 to 2030 #India #Bangalore #Divalproex_Sodium #Pharmaceutical_Market #Neurological_Disorders